Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIPERIDEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIPERIDEN: Safety Overview

Metric BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS BIPERIDEN
Total FAERS Reports 176 1,808
Deaths Reported 0 180
Death Rate N/A 10.0%
Hospitalizations 110 1,008
Average Patient Age 66.0 yrs 45.1 yrs
% Female Patients 91.7% 44.7%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Marketing Status N/A Discontinued